Financial assistance to support the Australian Medical Research and Innovation Priorities 2022-2024 reports on MRFF funding between 6 November 2022 and 5 November 2024.
During this time, the MRFF awarded 578 grants for research into areas, including:
- First Nations health
- clinical trials
- regional, rural and remote health
- public health
- health services
- consumer-led research.
All funding was awarded via competitive grant opportunities.
The MRFF report found that the fund continues to have a strong focus on medical research commercialisation, particularly for small and medium enterprises. Multiple programs have supported research discoveries as they progress from idea to clinical implementation.
Funding reached all states and territories. While Victoria received the largest share at 42.2%, most states and territories had close to the average funded rate of 21.5%.
Universities are leading the majority of these new projects (519), though in practice, grants are collaborative research efforts across multiple Australian locations and organisations.
Read the MRFF report to learn about:
- the alignment of MRFF funding with the 2022-2024 priorities set by the Australian Medical Research Advisory Board
- MRFF policy, performance and assurance activities
- grant selection processes
- other Australian Government support for medical research
- MRFF grant opportunities, outcomes and funding rates.
Discover the MRFF and its priorities.
